Disc Medicine to Participate in the Jefferies Global Healthcare Conference

Rhea-AI Summary

Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical firm, will present at the Jefferies Global Healthcare Conference on June 6th at 1:00 pm ET. The company focuses on developing treatments for serious hematologic diseases. A live webcast and an archived replay of the presentation will be accessible on the company's investor relations webpage.

Positive

• Company's participation in a prestigious conference increases visibility.
• Opportunity to attract potential investors and partners.
• Live webcast and archived replay enhance accessibility to information.

Negative

• No new clinical or financial updates provided in the announcement.
• The presentation alone may not significantly impact stock price.

WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will give a corporate presentation at the Jefferies Global Healthcare Conference on Thursday, June 6^th at 1:00 pm ET.

A live webcast of the presentation will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Verge Scientific Communications
prusconi@vergescientific.com

Investor Relations Contact

Christina Tartaglia
Stern Investor Relations
christina.tartaglia@sternir.com

FAQ

When will Disc Medicine present at the Jefferies Global Healthcare Conference?

Disc Medicine will present on June 6th at 1:00 pm ET.

Where can I watch the Disc Medicine presentation at the Jefferies Global Healthcare Conference?

A live webcast will be available on the investor relations section of Disc Medicine's website.

Will there be a replay of the Disc Medicine presentation?

Yes, an archived replay will be available after the event on the investor relations section of the website.

What is the stock symbol for Disc Medicine?

The stock symbol for Disc Medicine is IRON.

Is Disc Medicine a clinical-stage biopharmaceutical company?

Yes, Disc Medicine is focused on discovering and developing treatments for serious hematologic diseases.